Mostrando 10 resultados de: 14
Publisher
Frontiers in Aging Neuroscience(2)
Nutrients(2)
Scientific Reports(2)
Biomedicine and Pharmacotherapy(1)
Cell and Bioscience(1)
Área temáticas
Enfermedades(11)
Fisiología humana(5)
Salud y seguridad personal(5)
Farmacología y terapéutica(3)
Problemas sociales y servicios a grupos(3)
Origen
scopus(14)
Cohort profile: Design and methods of the PREDIMED-Plus randomized trial
ArticleAbstract:Palabras claves:Autores:Aldamiz M., Alfredo Martínez J., Alonso-Gómez A., Alvarez-Alvarez I., Ariz-Arnedo M.J., Aros F., Astrup A., Babio N., Barandiaran-Bengoetxea L., Barrientos I., Bartolome-Resano J., Basora J., Basterra Gortari J., Bes-Rastrollo M., Botella C., Buil-Cosiales P., Bulló M., Canales M., Cano-Valles B., Carlos Cenoz-Osinaga J., Castañer-Niño O., Cavanillas A.B., Corella D., Daimiel L., Delgado-Rodríguez M., Díez-Espino J., Eguaras S., Estremera-Urabayen V., Estruch R., Fernandez Alfaro C., Fernández-Avilés F., Fernández‐aranda F., Fitó M., Forga L., Fuertes-Goñi C., Galilea-Zabalza I., García-Arellano A., García-Layana A., Garcia-Perez M.L., García-Ríos A., Gómez-Gracia E., Goñi E., Goñi L., González-Pinto A., Güeto V., Guruchaga-Arcelus M.J., Hijos-Larraz C., Iñigo-Martinez B., José Francisco López-Gil, Lamuela-Raventós R.M., Lancova H., Lapetra J., Lecea-Juarez O., Lezaun-Indurain A., Lopez-Miranda J., Lozano-Oloriz E., Marcos A., Martin-Almendros S., Martínez-González M.A., Martínez-Kareaga M., Matía-Martín P., Navarrete-Muñoz E.M., Olmedo-Cruz O., Pascual Roquet-Jalmar E., Pi-Sunyer X., Pinto X., Portillo M.P., Portu J., Ramallal R., Razquin C., Rico A., Romaguera D., Ros E., Ruiz-Canela M., Sabate J., Sáez G., Salas-Salvadó J., Sánchez V.M., Sanchez-Tainta A., Sanjulián-Aranguren B., Sayon-Orea M.C., Schroder H., Seoane P., Serra-Majem L., Sola-Larraza A., Sorlí J.V., Stampfer M.J., Timiraos J., Tinahones F.J., Toledo E., Tur J.A., Vázquez C., Vázquez-Ruiz Z., Vidal J., Villanueva Moreno R., Vioque J., Wärnberg J., Zorrilla I., Zulet M.d.l.Á.Fuentes:scopusBenzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia
ArticleAbstract: Benzodiazepines (BZDs) and Z-drugs are compounds widely prescribed in medical practice due to theirPalabras claves:Alzheimer's disease, benzodiazepines, COGNITION, dementia, RISK FACTORSAutores:Antoni Camins, Auladell C., Bulló M., Busquets O., Cano A., Castro-Torres R.D., Ettcheto M., Folch J., García M.L., Manzine P.R., Olloquequi J., Sanchez-Lopez E., Zárate C.B.Fuentes:scopusA novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet
ArticleAbstract: Background: Alzheimer’s disease (AD) is characterized by a polyetiological origin. Despite the globaPalabras claves:Alzheimer’s disease, BACE1, BDNF, cognitive decline, dendritic spines, high-fat diet, neuroinflammation, Rhein-huprine hybrid, Tau, TLR4Autores:Antoni Camins, Auladell C., Bulló M., Cano A., Espinosa-Jimenez T., Ettcheto M., Folch J., Muñoz-Torrero D., Olloquequi J., Parcerisas A., Pont C., Sanchez-Lopez E., Verdaguer E.Fuentes:scopusGSPE pre-treatment protects against long-term cafeteria diet-induced mitochondrial and inflammatory affectations in the hippocampus of rats
ArticleAbstract: Deregulations like the loss of sensitivity to insulin (insulin resistance) and chronic inflammationPalabras claves:BRAIN, Cafeteria, diet, GSPE, hippocampus, inflammation, metabolism, StressAutores:Antoni Camins, Auladell C., Bulló M., Busquets O., Carrasco M., Espinosa-Jimenez T., Ettcheto M., Folch J., Pinent M., Rodríguez-Gallego E., Verdaguer E.Fuentes:scopusEffects of a psychosocial intervention at one-year follow-up in a PREDIMED-plus sample with obesity and metabolic syndrome
ArticleAbstract: This study examines if overweight/obesity are related to higher impulsivity, food addiction and deprPalabras claves:Autores:Bulló M., Corella D., Cuenca-Royo A.M., Díaz-López A., Fernández-Carrión R., Fernández‐aranda F., Forcano-Gamazo L., Galera A., Lozano-Madrid M.d.E., Mallorquí-Bague N., Murcia S.J., Pinto X., Roser Granero, Salas-Salvadó J., Torre R.d.l., Vintró-Alcaraz C.Fuentes:scopusEffects of nutrition on cognitive function in adults with or without cognitive impairment: A systematic review of randomized controlled clinical trials
ReviewAbstract: New dietary approaches for the prevention of cognitive impairment are being investigated. However, ePalabras claves:Alzheimer’s disease, cognitive impairment, diet, Dietary interventions, FOOD, Healthy, Subjective cognitive decline, SupplementsAutores:Antoni Camins, Atienza M., Bulló M., Cantero J.L., Folch A., Folch J., Gutierrez L., Papandreou C., Rojas M., Ruiz A.Fuentes:scopusJNK1 and JNK3: divergent functions in hippocampal metabolic-cognitive function
ArticleAbstract: Background and aim: The appearance of alterations in normal metabolic activity has been increasinglyPalabras claves:COGNITION, high-fat diet, JNK1, JNK3, metabolismAutores:Antoni Camins, Auladell C., Bulló M., Busquets O., Cantero J.L., Carro E., Casadesús G., Espinosa-Jimenez T., Ettcheto M., Folch J., Olloquequi J., Verdaguer E.Fuentes:scopusTransdiagnostic perspective of impulsivity and compulsivity in obesity: From cognitive profile to self-reported dimensions in clinical samples with and without diabetes
ArticleAbstract: Impulsive and compulsive behaviors have both been observed in individuals with obesity. The co-occurPalabras claves:Cognitive flexibility, Compulsivity, Decision Making, Harm avoidance, Impulsivity, Novelty seeking, Type 2 DiabetesAutores:Agüera Z., Baños R.M., Bertaina-Anglade V., Botella C., Bulló M., Camacho-Barcia L., Casanueva F.F., Dalsgaard S., Fernández-Real J.M., Fernández‐aranda F., Fitó M., Franke B., Frühbeck G., Gomez-Martinez C., Lucas I., Mora-Maltas B., Murcia S.J., Pinto X., Poelmans G., Roser Granero, Salas-Salvadó J., Serra-Majem L., Testa G., Tinahones F.J., Torre R.d.l., Vos S., Wimberley T.Fuentes:scopusTriple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease
ArticleAbstract:Palabras claves:Alzheimer’s disease, glucagon, glucagon-like peptide, glucose-dependent insulinotropic peptide, Type 2 DiabetesAutores:Antoni Camins, Auladell C., Bulló M., Busquets O., Castro-Torres R.D., Ettcheto M., Folch J., Manzine P.R., Olloquequi J., Sureda F.X., Verdaguer E., Zárate C.B.Fuentes:scopusType 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study
ArticleAbstract: This study cross-sectionally examines in the elderly population: (a) the association of type 2 diabePalabras claves:Autores:Abete I., Alonso-Gómez Á.M., Barragán R., Buil-Cosiales P., Bulló M., Castañer-Niño O., Cavanillas A.B., Corella D., Cuenca-Royo A.M., Daimiel L., Díaz-López A., Estruch R., Fernández‐aranda F., Gaforio J.J., García-de-la-Hera M., García-Ríos A., Lapetra J., Lopez-Miranda J., Lozano-Madrid M.d.E., Mallorquí-Bague N., Martínez J.A., Martínez-González M.A., Matía-Martín P., Murcia S.J., Pinto X., Romaguera D., Ros E., Roser Granero, Ruiz-Canela M., Salas-Salvadó J., Sánchez V.M., Serra-Majem L., Tinahones F.J., Toledo E., Torre R.d.l., Tur J.A., Vázquez C., Vidal J., Vioque J., Wärnberg J., Yáñez A.M.Fuentes:scopus